Effect of modified Zhengqi Powder in treating chronic gastritis and on patients' life quality and inflammatory factors.
10.19540/j.cnki.cjcmm.2019.0004
- Author:
Xin-Qiao LIU
1
;
Ling WANG
1
Author Information
1. Beijing Anzhen Hospital Affiliated to Capital Medical University Beijing 100029,China.
- Publication Type:Journal Article
- Keywords:
chronic gastritis;
cytokines;
intestinal metaplasia;
modified Zhengqi Powder;
spleen and stomach wet and heat syndrome;
the quality of life
- MeSH:
C-Reactive Protein;
analysis;
Drugs, Chinese Herbal;
therapeutic use;
Gastric Mucosa;
drug effects;
Gastritis, Atrophic;
drug therapy;
Humans;
Interleukin-8;
blood;
Metaplasia;
drug therapy;
Quality of Life;
Tumor Necrosis Factor-alpha;
blood
- From:
China Journal of Chinese Materia Medica
2019;44(1):181-185
- CountryChina
- Language:Chinese
-
Abstract:
Chronic gastritis is a kind of chronic gastric mucosal inflammation caused by many factors.Intestinal metaplasia refers to the transformation of gastric mucosal epithelial cells into small/large intestinal mucosal epithelium containing Panette or goblet cells.Chronic gastritis has the highest incidence among stomach diseases,while intestinal metaplasia is the serious manifestation of chronic gastritis.In this experiment,the therapeutic effect of modified Zhengqi Powder on mild intestinal metaplasia in chronic gastritis and on patients' quality of life and inflammatory reaction was investigated to analyze the efficacy and mechanism of traditional Chinese medicine prescription.From April 2016 to April 2017,120 patients of chronic gastritis with mild intestinal metaplasia were selected and divided into two groups according to the envelope method.The control group(60 cases) was treated with famoxetine.After one month of continuous treatment,the total effective rate of treatment in the observation group was 93.3%,which was much higher than 80.0% in the control group.Health questionnaire(SF-36),serum C-reactive protein(CRP),interleukin-8(IL-8) and tumor necrosis factor-α(TNF-α) levels were significantly higher than those in the control group(P<0.05).The results showed that modified Zhengqi Powder has a significant efficacy in treat chronic gastritis with mild intestinal metaplasia,and can obviously alleviate clinical symptoms and intestinal metaplasia,remove inflammatory factors and improve the quality of life of patients,and is worth promotion.
